ATE374838T1 - Nukleotidsequenzvariation im gen ns5a als marker - Google Patents
Nukleotidsequenzvariation im gen ns5a als markerInfo
- Publication number
- ATE374838T1 ATE374838T1 AT05008605T AT05008605T ATE374838T1 AT E374838 T1 ATE374838 T1 AT E374838T1 AT 05008605 T AT05008605 T AT 05008605T AT 05008605 T AT05008605 T AT 05008605T AT E374838 T1 ATE374838 T1 AT E374838T1
- Authority
- AT
- Austria
- Prior art keywords
- marker
- nucleotide sequence
- sequence variation
- ns5a gene
- ns5a
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56627404P | 2004-04-29 | 2004-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE374838T1 true ATE374838T1 (de) | 2007-10-15 |
Family
ID=34935435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05008605T ATE374838T1 (de) | 2004-04-29 | 2005-04-20 | Nukleotidsequenzvariation im gen ns5a als marker |
Country Status (8)
Country | Link |
---|---|
US (2) | US7504217B2 (de) |
EP (1) | EP1591539B1 (de) |
JP (1) | JP4097662B2 (de) |
CN (1) | CN100422346C (de) |
AT (1) | ATE374838T1 (de) |
CA (1) | CA2503336A1 (de) |
DE (1) | DE602005002673T2 (de) |
ES (1) | ES2294589T3 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102307589A (zh) * | 2008-08-28 | 2012-01-04 | 沃泰克斯药物股份有限公司 | Hcv的基因型分析 |
EP2408449A4 (de) * | 2009-03-18 | 2012-08-08 | Univ Leland Stanford Junior | Verfahren und zusammensetzungen zur behandlung von flaviviridae-virusinfektionen |
US20100316608A1 (en) * | 2009-06-15 | 2010-12-16 | Vijayaprakash Suppiah | Method of Determining A Response To Treatment With Immunomodulatory Composition |
MX2012011804A (es) * | 2010-04-13 | 2012-12-17 | Hoffmann La Roche | Polimorfismos de un solo nucleotido que predicen resultados de tratamiento de hcv. |
US9175332B2 (en) * | 2010-07-29 | 2015-11-03 | Roche Molecular Systems, Inc. | Generic PCR |
US20120077738A1 (en) * | 2010-09-24 | 2012-03-29 | Wisconsin Alumni Research Foundation | Compositions and methods for predicting hcv susceptibility to antiviral agents |
KR101247769B1 (ko) | 2011-02-18 | 2013-03-25 | 한림대학교 산학협력단 | 인터페론 알파 저항성 c형 간염 바이러스 |
AU2013205064B2 (en) * | 2012-06-04 | 2015-07-30 | Gen-Probe Incorporated | Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid |
CN107699636B (zh) * | 2017-11-10 | 2019-03-15 | 黑龙江金域医学检验所有限公司 | 用于检测HCV 2a亚型NS5A耐药突变基因的扩增引物、应用及检测方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6433159B1 (en) * | 1992-09-10 | 2002-08-13 | Isis Pharmaceuticals, Inc. | Compositions and methods for treatment of Hepatitis C virus associated diseases |
EP0858343B1 (de) | 1995-11-02 | 2004-03-31 | Schering Corporation | Kontinuierliche, niedrigdosierte zytokine-infusionstherapie |
AUPN976596A0 (en) | 1996-05-09 | 1996-05-30 | Pharma Pacific Pty Ltd | Stimulation of host defence mechanisms |
IL131730A (en) * | 1997-03-05 | 2004-06-20 | Univ Washington | Screening methods to identify factors that selectively inhibit hepatitis C virus replication |
US20030028011A1 (en) | 1997-07-30 | 2003-02-06 | Parkin Neil T. | Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs |
JP2002543144A (ja) | 1999-05-04 | 2002-12-17 | シェーリング コーポレイション | PEG化インターフェロンαCCR5アンタゴニスト併用HIV療法 |
ATE375804T1 (de) * | 2000-08-17 | 2007-11-15 | Tripep Ab | Ribavirin-enthaltende vakzine |
CN1093172C (zh) * | 2001-03-19 | 2002-10-23 | 杨凌岱鹰生物工程股份有限公司 | 丙型肝炎全病毒及其体外细胞培养方法 |
US7183302B2 (en) | 2002-08-12 | 2007-02-27 | Bristol-Myers Squibb Company | Iminothiazolidinones as inhibitors of HCV replication |
KR100520529B1 (ko) * | 2003-09-16 | 2005-10-11 | 현대자동차주식회사 | 차량용 6속 자동 변속기의 유압 제어시스템 |
-
2005
- 2005-04-20 ES ES05008605T patent/ES2294589T3/es active Active
- 2005-04-20 EP EP05008605A patent/EP1591539B1/de not_active Not-in-force
- 2005-04-20 AT AT05008605T patent/ATE374838T1/de not_active IP Right Cessation
- 2005-04-20 DE DE602005002673T patent/DE602005002673T2/de active Active
- 2005-04-26 CA CA002503336A patent/CA2503336A1/en active Pending
- 2005-04-27 US US11/117,667 patent/US7504217B2/en not_active Expired - Fee Related
- 2005-04-29 CN CNB2005100685279A patent/CN100422346C/zh not_active Expired - Fee Related
- 2005-05-02 JP JP2005134408A patent/JP4097662B2/ja not_active Expired - Fee Related
-
2009
- 2009-01-16 US US12/321,164 patent/US20090148831A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005312454A (ja) | 2005-11-10 |
EP1591539A1 (de) | 2005-11-02 |
US20050260567A1 (en) | 2005-11-24 |
EP1591539B1 (de) | 2007-10-03 |
ES2294589T3 (es) | 2008-04-01 |
JP4097662B2 (ja) | 2008-06-11 |
US7504217B2 (en) | 2009-03-17 |
DE602005002673T2 (de) | 2008-07-24 |
CA2503336A1 (en) | 2005-10-29 |
DE602005002673D1 (de) | 2007-11-15 |
CN1693482A (zh) | 2005-11-09 |
US20090148831A1 (en) | 2009-06-11 |
CN100422346C (zh) | 2008-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE374838T1 (de) | Nukleotidsequenzvariation im gen ns5a als marker | |
DE602005009702D1 (de) | Esr1 und gebärmutterhalskrebs | |
MXPA05005945A (es) | Evento asr-368 de agrostis y composiciones y metodos para deteccion del mismo. | |
TW200745556A (en) | Biomarkers for liver fibrotic injury | |
HK1204480A1 (en) | Methods and materials using signaling probes | |
NO20054078D0 (no) | Humane antistoffer spesifikke for Interleukin 15 (IL15). | |
DE602005016892D1 (de) | Nukleinsäurecharakterisierung | |
DE60322339D1 (de) | Bindungsproteine als biosensoren | |
ATE527385T1 (de) | Mit tumoren assoziierte genetische variationen | |
ATE480642T1 (de) | Verfahren zur bestimmung von genotoxizität | |
DK1842920T3 (da) | Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein | |
ATE446385T1 (de) | Polymorphismen im nod2/card15 gen | |
DE60326748D1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
SE0301951D0 (sv) | New method | |
DE602004016499D1 (de) | Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung | |
DK1814907T3 (da) | Sæt af dele til designet til implementering af en antitumoral eller antiviral behandling hos et pattedyr | |
WO2006012356A3 (en) | Methods for determining risk of developing regular smoking behavior | |
ATE441728T1 (de) | Mit cmv-resistenz assoziierter molekularer marker und verwendung davon | |
O'Brien et al. | Meeting Overview: Interferon Lambda—Disease Impact and Therapeutic Potential | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
SE0300959D0 (sv) | Methods for predicting therapeutic response to agents acting on the growth hormone receptor | |
ATE406461T1 (de) | Rna-bioassay | |
DE602005027414D1 (de) | Verfahren zur übertragung episomaler vektoren in tierzellen | |
ATE489483T1 (de) | Assoziation von pde4d-allelvarianten mit schlaganfall | |
SE9900615L (sv) | Metod och kit för tidig förutsägelse av cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |